Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Terlipressin for Injection

Approval Number

国药准字H20223270

Company福建省闽东力捷迅药业股份有限公司

Registration Date

April 29, 2022

Drug Information

Generic Name

注射用特利加压素

Dosage Form

注射剂

Strength

1mg（相当于0.86mg特利加压素）

Drug Type

化学药品

Registration Date

April 29, 2022

Company Information

Applicant Company

Company Name福建省闽东力捷迅药业股份有限公司

Company Address

福建省柘荣县制药工业路1号

Manufacturing Company

Company Name福建省闽东力捷迅药业股份有限公司

Company Address

福建省柘荣县制药工业路1号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy